| Beyond the Abstract - Everolimus for the treatment of advanced renal cell ... - UroToday |
|
|
UroToday Renal cell carcinoma (RCC) is an attractive clinical target for everolimus therapy because of the dysregulated signaling through mTOR, the highly vasculized nature of renal causing RCC to possess a higher concentration of angiogenic factors, |